166 related articles for article (PubMed ID: 38063042)
1. Pyroptosis in glioma: Current management and future application.
Guo Z; Su Z; Wei Y; Zhang X; Hong X
Immunol Rev; 2024 Jan; 321(1):152-168. PubMed ID: 38063042
[TBL] [Abstract][Full Text] [Related]
2. Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response.
Cai Y; Li K; Lin J; Liang X; Xu W; Zhan Z; Xue S; Zeng Y; Chai P; Mao Y; Song Z; Han L; Song Y; Zhang X; Wang H
Front Immunol; 2022; 13():910490. PubMed ID: 35784306
[TBL] [Abstract][Full Text] [Related]
3. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of pyroptosis and its role in anti-tumor immunity.
Huang H; Weng Y; Tian W; Lin X; Chen J; Luo L
Int J Biol Sci; 2023; 19(13):4166-4180. PubMed ID: 37705746
[TBL] [Abstract][Full Text] [Related]
5. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
[TBL] [Abstract][Full Text] [Related]
6. A self-assembling CXCR4-targeted pyroptosis nanotoxin for melanoma therapy.
Zhao Z; Huang Y; Wang J; Lin H; Cao F; Li S; Li Y; Li Z; Liu X
Biomater Sci; 2023 Mar; 11(6):2200-2210. PubMed ID: 36745434
[TBL] [Abstract][Full Text] [Related]
7. Pyroptosis: A road to next-generation cancer immunotherapy.
Fang Y; Tang Y; Huang B
Semin Immunol; 2023 Jul; 68():101782. PubMed ID: 37302166
[TBL] [Abstract][Full Text] [Related]
8. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
Chen J; Chen S; Li B; Zhou S; Lin H
Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
[TBL] [Abstract][Full Text] [Related]
9. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma.
He J; Zhou W; Zhang M
Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887
[TBL] [Abstract][Full Text] [Related]
10. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.
Mishchenko TA; Turubanova VD; Gorshkova EN; Krysko O; Vedunova MV; Krysko DV
Front Immunol; 2023; 14():1299064. PubMed ID: 38274827
[TBL] [Abstract][Full Text] [Related]
11. Gasdermins and cancers.
Hou J; Li T; Hsu JM; Zhang X; Hung MC
Semin Immunol; 2023 Nov; 70():101833. PubMed ID: 37647772
[TBL] [Abstract][Full Text] [Related]
12. [Anti-glioma mechanism of pterostilbene by regulating apoptosis and GSDME-mediated pyroptosis pathways: a study based on network pharmacology and experimental research].
Chen Z; Fang XG; Guo XR; Luan SQ; Hua J; Luo J
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3589-3601. PubMed ID: 37474992
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the Role of Pyroptosis in Lower-Grade Glioma: Development of a Novel Scoring System to Enhance Personalized Therapeutic Approaches.
Chen X; Xu Y; Wang M; Ren C
J Mol Neurosci; 2023 Aug; 73(7-8):649-663. PubMed ID: 37566191
[TBL] [Abstract][Full Text] [Related]
14. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment.
Li M; Jiang P; Yang Y; Xiong L; Wei S; Wang J; Li C
Exp Hematol Oncol; 2023 Dec; 12(1):103. PubMed ID: 38066523
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment.
Wang A; Wang Y; Du C; Yang H; Wang Z; Jin C; Hamblin MR
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189058. PubMed ID: 38113952
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Bioinformatics Analysis of Gasdermin Family of Glioma.
Zi H; Tuo Z; He Q; Meng J; Hu Y; Li Y; Yang K
Comput Intell Neurosci; 2022; 2022():9046507. PubMed ID: 35463276
[TBL] [Abstract][Full Text] [Related]
17. Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression.
Li L; Wu L; Yin X; Li C; Hua Z
Oxid Med Cell Longev; 2022; 2022():1803544. PubMed ID: 36199426
[TBL] [Abstract][Full Text] [Related]
18. GSDMA at the crossroads between pyroptosis and tumor immune evasion in glioma.
Zhang R; Song Q; Lin X; Du B; Geng D; Gao D
Biochem Biophys Res Commun; 2023 Dec; 686():149181. PubMed ID: 37924669
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis-induced inflammation and tissue damage.
Vasudevan SO; Behl B; Rathinam VA
Semin Immunol; 2023 Sep; 69():101781. PubMed ID: 37352727
[TBL] [Abstract][Full Text] [Related]
20. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
